- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: plasma glucose concentration
Total 29102 results
-
Lundbeck LLCWithdrawn
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Purdue Pharma LPCompleted
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
University of TorontoNatural Sciences and Engineering Research Council, Canada; Mondelēz International... and other collaboratorsCompletedHealthy | Glucose MetabolismCanada
-
Novartis PharmaceuticalsCompletedHeart FailureRussian Federation, Germany, Poland
-
Northwell HealthCompleted
-
Seoul National University Bundang HospitalUnknownGastric CancerKorea, Republic of
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2 | Type 2 Diabetes MellitusUnited States
-
NovartisCompletedOsteoarthritis | Rheumatoid Arthritis
-
NovartisCompletedOsteoarthritisCzech Republic, Germany, Finland, Hungary, Australia, Austria, Turkey, Poland, Israel, Spain, South Africa, Slovakia, Sweden, Netherlands, New Zealand
-
Pontificia Universidad Catolica de ChileCompletedTransversus Abdominis Plane BlockChile
-
Institute for Clinical and Experimental MedicineCompletedType 2 Diabetes | Postprandial Oxidative StressCzech Republic
-
Tehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Peter BangCompletedType 1 Diabetes MellitusSweden
-
China Medical University HospitalCompletedType 2 Diabetes Mellitus With Features of Insulin ResistanceTaiwan
-
GlaxoSmithKlineCompletedHealthy VolunteerUnited Kingdom
-
Wageningen UniversityCompleted
-
Vanderbilt UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Terminated
-
InLight SolutionsUnknownType 1 Diabetes | Type 2 Diabetes | Gestational DiabetesUnited States
-
University Hospital, Clermont-FerrandUnither PharmaceuticalsCompleted
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetic of DigoxinFrance
-
Astellas Pharma IncCompletedHealthy Elderly Subject | Pharmacokinetic of YM150Japan
-
IRCCS Policlinico S. MatteoCompleted
-
University of ManitobaCompletedHypercholesterolemiaCanada
-
Center for Health, Exercise and Sport Sciences,...Completed
-
Minneapolis Veterans Affairs Medical CenterCompletedMetabolic Syndrome | Type 2 Diabetes | Blood Glucose ConcentrationUnited States
-
Technische Universität DresdenCompletedType 2 Diabetes | Overt Diabetic NephropathyGermany
-
Gulhane School of MedicineCompleted
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy | Pharmacokinetics of ASP1941Taiwan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
AstraZenecaCompletedMetabolic SyndromeTurkey
-
PfizerCompletedPharmacokinetics | Safety | Phase 1 | Single Dose | TolerationBelgium
-
Manhattan Psychiatric CenterPfizerCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
University Medical Center GroningenCompleted
-
Glostrup University Hospital, CopenhagenUniversity of Copenhagen; European Foundation for the Study of DiabetesCompletedInsulin Resistance | Inactivity | Deteriorated Glucose HomeostasisDenmark
-
Renal Research InstituteCompletedHemodialysis | ESRDUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
University of LimerickIrish Research CouncilCompleted
-
University Hospital, BordeauxCompleted
-
Hospitales Universitarios Virgen del RocíoCompletedPlasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily (RAET)HIV Infections | HIV-1 InfectionSpain
-
Korea UniversityCompletedSEPP1 Levels in Differnet Glucose Tolerance Status
-
AstraZenecaCompleted
-
University of ZurichIxodes GmbH; Appletree AGCompletedLyme DiseaseSwitzerland
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States
-
Bows Pharmaceuticals AGSuspendedDiabetes MellitusSweden
-
Bows Pharmaceuticals AGSuspended